|
Maria T. Abreu, MD
Associate Professor of Medicine
Director of IBD Center
Mount Sinai School of Medicine
New York, NY
Disclosure: Dr. Abreau has served as an advisor or consultant to Procter & Gamble, Abbott, UCB, Schering, and Berlex. Dr. Abreu has also served on the speaker's bureau for Procter & Gamble, Abbott, Salix Pharmaceuticals, and Prometheus.
Stephen Hanauer, MD
Professor of Medicine and Clinical Pharmacology
Chief, Section of Gastroenterology and Nutrition Center for Advanced Medicine
University of Chicago,
Chicago, IL
Disclosure: Dr. Hanauer has received grants for clinical research from Centocor, Abbott, UCB, Procter & Gamble, PDL, Shire, Elan, Otsuka, Ashi, and Prometheus. Dr. Hanauer has also received grants for educational activities from UCB, Procter & Gamble, and Prometheus. Dr. Hanauer has also has served as an advisor or consultant to Centocor, Abbott, UCB, Procter & Gamble, PDL, Shire, Salix, Elan, Otsuka, Ashi, and Prometheus.
David Rubin, MD
Division of Biological Sciences
Section of Gastroenterology
Assistant Professor of Medicine
Director, GI Fellowship Program
University of Chicago
Chicago, IL
Disclosure: Dr. Rubin has received grants for clinical research from Procter & Gamble, Prometheus, Given Imaging, and Bimerica. Dr. Rubin has also served as an advisor or consultant to Procter & Gamble, Salix, Prometheus, Abbott, UCB Pharma, Given Imaging, and Shire, and that he has served on the speaker's bureau for Procter & Gamble, Salix, Prometheus, and Abbott.
Disclaimer: The opinions and recommendations expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Use of the HealthXplorer name implies review of educational format design and approach.
|
|
